SCHEMBL1291013

SCHEMBL1291013

CN(c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O)S(C)(=O)=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 8/20 1.00
CDK2 P24941 7/20 1.00
CDC42BPA Q5VT25 2/20 1.00
CDK1 P06493 2/20 1.00
CDK5 Q00535 2/20 1.00
SRPK1 Q96SB4 2/20 1.00
ROCK2 O75116 6/20 0.65
SLK Q9H2G2 3/20 0.65
FLT3 P36888 2/20 0.65
FER P16591 2/20 0.65
PDPK1 O15530 1/20 0.65
FES P07332 1/20 0.65
MARK3 P27448 1/20 0.65
MAP4K2 Q12851 1/20 0.65
PKN2 Q16513 1/20 0.65
PIM2 Q9P1W9 1/20 0.65
KDR P35968 2/20 0.56
CHEK1 O14757 9/20 0.56
GSK3B P49841 5/20 0.52
CSF1R P07333 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1290969 0.90 IRAK4 (0.81) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290868 0.90 IRAK4 (0.81) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290897 0.90 IRAK4 (0.81) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1291080 0.89 IRAK4 (0.80) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290898 0.88 IRAK4 (0.79) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290829 0.88 IRAK4 (0.78) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290992 0.87 IRAK4 (0.77) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290852 0.87 IRAK4 (0.77) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1290749 0.87 IRAK4 (0.77) IRAK4CDK2CDC42BPACDK1CDK5
SCHEMBL1291126 0.87 IRAK4 (0.77) IRAK4CDK2CDC42BPACDK1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012045194-A1 BENZODIAZEPINONES AS FAK INHIBITORS FOR TREATMENT OF CANCER ABBOTT LABORATORIES (US) 2012-04-12 WO claimed